ta388

CCG Briefing on Sacubitril Valsartan (Entresto®) NICE Technology Appraisal Guidance TA388

This briefing is designed to inform CCGs of the implications of NICE TAG 388 Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction.